• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Conference coverage

HRS2014: Boston Scientific’s S-ICD strong at 22 months, promising in post-ICD patients

May 8, 2014 By Arezu Sarvestani Leave a Comment

HRS2014: Boston Scientific's S-ICD strong at 22 months, even in post-ICD patients

Filed Under: Cardiac Implants, News Well Tagged With: Boston Scientific, Cardiac Rhythm Management, Conference coverage, Heart Rhythm Society, HRS 2014

HRS2014: Medtronic cardiac rhythm implants fail 1st in head-to-head studies of longevity, researchers say

May 8, 2014 By Arezu Sarvestani Leave a Comment

HRS2014: Medtronic CRTs have shortest life, researchers report

Filed Under: Cardiac Implants, News Well Tagged With: Biotronik, Boston Scientific, Cardiac Rhythm Management, Clinical Trials, Conference coverage, Heart Rhythm Society, HRS 2014, stjudemedical

HRS2014: Boston Scientific’s S-ICD causes few complications

May 8, 2014 By Arezu Sarvestani Leave a Comment

HRS2014: Boston Scientific's S-ICD causes few complications

Boston Scientific’s (NYSE:BSX) lead-free S-ICD cardiac rhythm management made another strong showing, with results from an analysis of more than 880 patients showing relatively few complications.

Filed Under: News Well Tagged With: Boston Scientific, Cameron Health Inc., Cardiac Rhythm Management, Clinical Trials, Conference coverage, Heart Rhythm Society, HRS 2014

HRS2014: Devices combat drugs for treatment of AF stroke-risk patients

May 8, 2014 By Arezu Sarvestani Leave a Comment

HRS2014: LA appendage occlusion beats drugs in the right patients

New clinical data continues to suggest that left atrial appendage occlusion devices may pose an improvement over warfarin drug regimens for treating patients at increased risk of stroke, researchers reported today.

Filed Under: News Well, Structural Heart Tagged With: Boston Scientific, Cardiac Rhythm Management, Coherex Medical, Conference coverage, Heart Rhythm Society, HRS 2014, stjudemedical, Stroke

HRS14: St. Jude’s quadripolar pacing wins in 1st head-to-head study

May 8, 2014 By Arezu Sarvestani Leave a Comment

HRS14: St. Jude Medical's quadripolar pacing wins 1st head-to-head study

Filed Under: News Well Tagged With: Cardiac Rhythm Management, Clinical Trials, Conference coverage, Heart Rhythm Society, HRS 2014, stjudemedical

The view from HRS 2014: This week at the Heart Rhythm Society’s 35th Annual Scientific Sessions

May 7, 2014 By Arezu Sarvestani Leave a Comment

The view from HRS 2014:

Things are still pretty quiet on opening day of Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions in semi-sunny San Francisco, but the week is shaping up to be a busy one.

There are few major announcements expected from this year’s sessions, but attendees are looking forward to some important updates on key new technologies and trends in cardiac pacing and electrophysiology, coming from the biggest players in the market.

Filed Under: News Well Tagged With: Cardiac Rhythm Management, Conference coverage, Heart Rhythm Society, HRS 2014

ACC14: The quickening pace of change

April 7, 2014 By MassDevice Leave a Comment

By Westby G. Fisher, MD, FACC

Westby Fisher

I just returned from the American College of Cardiology and wanted to write down a few of my 50,000-foot impressions from the meeting for, as the song goes, the times, they are a-changin’.

Filed Under: Blog, News Well Tagged With: American College of Cardiology, American College of Cardiology Conference (ACC), Conference coverage, Dr. Wes

ACC 2014: Conflicts in renal denervation, competition in valves

April 3, 2014 By Arezu Sarvestani Leave a Comment

fired/hired

The American College of Cardiology’s annual Scientific Sessions are regularly a source of controversy and competition, but medtech titan Medtronic’s (NYSE:MDT) highly anticipated renal denervation study results may have been the most confounding.

Filed Under: News Well, Replacement Heart Valves Tagged With: ACC 2014, American College of Cardiology Conference (ACC), Boston Scientific, Clinical Trials, Conference coverage, Edwards Lifesciences, Hypertension, Renal

J.P. Morgan medtech wrap-up: Ups and downs from San Francisco

January 16, 2014 By MassDevice staff Leave a Comment

J.P. Morgan medtech wrap-up: Ups and downs from San Francisco

Medtronic CEO: Value-based healthcare is the only way to save medtech

Filed Under: News Well Tagged With: Boston Scientific, Conference coverage, Covidien, Edwards Lifesciences, Intuitive Surgical, J.P. Morgan Healthcare Conference, JP Morgan Chase, stjudemedical, Thoratec Corp.

NuVasive soars on estimates for Q4 and 2014

January 15, 2014 By Arezu Sarvestani Leave a Comment

NuVasive soars on new outlook, preliminary earnings

California medical device maker NuVasive Inc. (NSDQ:NUVA) is flying high today after raising its revenue projections for 2013 amid higher-than-expected 4th quarter sales.

Filed Under: MassDevice Earnings Roundup, News Well, Spine, Wall Street Beat Tagged With: Conference coverage, J.P. Morgan Healthcare Conference, Minimally Invasive Surgery, Nuvasive

Intuitive Surgical CEO responds to hubbub over adverse events

January 14, 2014 By Arezu Sarvestani Leave a Comment

Intuitive Surgical CEO responds to hubbub over adverse events

Filed Under: News Well, Robotics Tagged With: Conference coverage, Intuitive Surgical, J.P. Morgan Healthcare Conference, Patient Safety

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 8
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS